Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 4
2022 5
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy.
Turco F, Tucci M, Delcuratolo MD, Di Stefano RF, Pisano C, Audisio A, Audisio M, Ungaro A, Ortega C, Di Maio M, Scagliotti GV, Buttigliero C. Turco F, et al. Among authors: delcuratolo md. Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22. Cancer Commun (Lond). 2022. PMID: 35866986 Free PMC article. No abstract available.
Major breakthroughs in lung cancer adjuvant treatment: Looking beyond the horizon.
Passiglia F, Bertaglia V, Reale ML, Delcuratolo MD, Tabbò F, Olmetto E, Capelletto E, Bironzo P, Novello S. Passiglia F, et al. Among authors: delcuratolo md. Cancer Treat Rev. 2021 Dec;101:102308. doi: 10.1016/j.ctrv.2021.102308. Epub 2021 Oct 18. Cancer Treat Rev. 2021. PMID: 34757306 Review.
Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed.
Leonetti A, Perrone F, Puntoni M, Maglietta G, Bordi P, Bria E, Vita E, Gelsomino F, De Giglio A, Gelibter A, Siringo M, Mazzoni F, Caliman E, Genova C, Bertolini F, Guaitoli G, Passiglia F, Delcuratolo MD, Montrone M, Cerea G, Pasello G, Roca E, Belluomini L, Cecere FL, Guida A, Manzo A, Adamo V, Rastelli F, Bulotta A, Citarella F, Toschi L, Zoratto F, Cortinovis DL, Berardi R, Follador A, Carta A, Camerini A, Salerno F, Silva RR, Baldini E, Cortellini A, Brighenti M, Santoni M, Malorgio F, Caminiti C, Tiseo M. Leonetti A, et al. Among authors: delcuratolo md. Eur J Cancer. 2024 May;202:114006. doi: 10.1016/j.ejca.2024.114006. Epub 2024 Mar 11. Eur J Cancer. 2024. PMID: 38489861
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma.
Samuelly A, Di Stefano RF, Turco F, Delcuratolo MD, Pisano C, Saporita I, Calabrese M, Carfì FM, Tucci M, Buttigliero C. Samuelly A, et al. Among authors: delcuratolo md. J Clin Med. 2024 Jan 5;13(2):307. doi: 10.3390/jcm13020307. J Clin Med. 2024. PMID: 38256441 Free PMC article. Review.
13 results